Prostate cancer remains one of the highest incidence of cancer in men.
Despite this, 68% of men are either overdue or have never gotten a PSA measurement2
U-GEN wants to meet the patients where they are. We know PSA tests and DRE are not going anywhere any time soon, we want to still be able help provide care to those either unwilling or unable to get screening done the traditional way. With a Sensitivity of 94% and Negative Predictive Value (NPV) of 95% you can trust that your patients are in good hands.
If you think your patient would benefit from our test, just place an order *insert link here*
Our simple collection kit with preservation solution will be sent to the patient doorstep, so no need to take time out of their busy schedule
They will be able to ship it right to our lab staffed with experts using an easy prepaid return box
We will send you the results so you can keep making the best decisions for your patients
References
- Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4. PMID: 38572751
- National Center for Health Statistics. 2023 National Health Interview Survey (NHIS) Cancer Control Supplement (CCS). Centers for Disease Control and Prevention; 2024. Accessed April 12, 2026. https://cdc.gov/nchs/nhis/documentation/2023-nhis.html